| payload |
{"created_at":"2026-04-08T11:34:02.408 {"created_at":"2026-04-08T11:34:02.408899+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/nurix-therapeutics-posts-wider-loss-q1","value":{"fp":"537ba2175bf8454c","kind":"unusual_volume","published_at":"2026-04-08T10:57:51+00:00","source":"Nasdaq Markets","summary":"(RTTNews) - Nurix Therapeutics, Inc. (NRIX) reported a first quarter net loss of $87.2 million or $0.79 per share compared with a net loss of $56.4 million or $0.67 per share, prior year. Revenue was $6.3 million compared with $18.5 million, a year ago. The company said revenue f","tickers":["NRIX"],"title":"Nurix Therapeutics Posts Wider Loss In Q1","url":"https://www.nasdaq.com/articles/nurix-therapeutics-posts-wider-loss-q1"}}... |